126 related articles for article (PubMed ID: 1613748)
1. Iodoaminopotentidine and related compounds: a new class of ligands with high affinity and selectivity for the histamine H2 receptor.
Hirschfeld J; Buschauer A; Elz S; Schunack W; Ruat M; Traiffort E; Schwartz JC
J Med Chem; 1992 Jun; 35(12):2231-8. PubMed ID: 1613748
[TBL] [Abstract][Full Text] [Related]
2. Reversible and irreversible labeling and autoradiographic localization of the cerebral histamine H2 receptor using [125I]iodinated probes.
Ruat M; Traiffort E; Bouthenet ML; Schwartz JC; Hirschfeld J; Buschauer A; Schunack W
Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1658-62. PubMed ID: 2308927
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro pharmacology of arpromidine and related phenyl(pyridylalkyl)guanidines, a potential new class of positive inotropic drugs.
Buschauer A
J Med Chem; 1989 Aug; 32(8):1963-70. PubMed ID: 2569042
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of histamine H2-agonists, a new class of positive inotropic drugs.
Buschauer A; Baumann G
Agents Actions Suppl; 1991; 33():231-56. PubMed ID: 1828931
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and histamine H2-receptor activity of heterocyclic impromidine analogues.
Buschauer A; Lachenmayr F; Schunack W
Pharmazie; 1992 Feb; 47(2):86-91. PubMed ID: 1353262
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and histamine H2-agonistic activity of ring-substituted phenyl analogues of impromidine.
Buschauer A; Lachenmayr F; Schunack W
Pharmazie; 1991 Dec; 46(12):840-5. PubMed ID: 1687832
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization and autoradiographic localization of histamine H2 receptors in human brain identified with [125I]iodoaminopotentidine.
Traiffort E; Pollard H; Moreau J; Ruat M; Schwartz JC; Martinez-Mir MI; Palacios JM
J Neurochem; 1992 Jul; 59(1):290-9. PubMed ID: 1351926
[TBL] [Abstract][Full Text] [Related]
8. [Quinazolinones. 18. Synthesis and H1/H2-antihistaminic action of omega-[2-aryl-2,3-dihydro-4(1H)-quinazolinone-1-yl]alkyl substituted ureas and cyanoguanidines].
Büyüktimkin S; Buschauer A; Schunack W
Arch Pharm (Weinheim); 1991 May; 324(5):291-5. PubMed ID: 1679625
[TBL] [Abstract][Full Text] [Related]
9. Potential histamine H2-receptor antagonists. 2. N-alpha-Guanylhistamine.
Durant GJ; Parsons ME; Black JW
J Med Chem; 1975 Aug; 18(8):830-3. PubMed ID: 240023
[TBL] [Abstract][Full Text] [Related]
10. Conformational requirements for histamine H2-receptor inhibitors: a structure-activity study of phenylene analogues related to cimetidine and tiotidine.
Hoffman JM; Pietruszkiewicz AM; Habecker CN; Phillips BT; Bolhofer WA; Cragoe EJ; Torchiana ML; Lumma WC; Baldwin JJ
J Med Chem; 1983 Feb; 26(2):140-4. PubMed ID: 6131129
[TBL] [Abstract][Full Text] [Related]
11. 4- or 5- (omega-aminoalkyl) thiazoles and derivatives; new selective H2-receptor agonists.
Eriks JC; Sterk GJ; van der Aar EM; van Acker SA; van der Goot H; Timmerman H
Agents Actions Suppl; 1991; 33():301-14. PubMed ID: 1828933
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and histamine H1 receptor agonist activity of a series of 2-phenylhistamines, 2-heteroarylhistamines, and analogues.
Leschke C; Elz S; Garbarg M; Schunack W
J Med Chem; 1995 Apr; 38(8):1287-94. PubMed ID: 7731015
[TBL] [Abstract][Full Text] [Related]
13. Histamine H2-receptor agonists. Synthesis, in vitro pharmacology, and qualitative structure-activity relationships of substituted 4- and 5-(2-aminoethyl)thiazoles.
Eriks JC; van der Goot H; Sterk GJ; Timmerman H
J Med Chem; 1992 Aug; 35(17):3239-46. PubMed ID: 1507209
[TBL] [Abstract][Full Text] [Related]
14. [Impromidine-analogous guanidines: synthesis and activity at the histamine H2-receptor. 29. Histamine analogs].
Elz S; Schunack W
Arzneimittelforschung; 1988 Mar; 38(3):327-32. PubMed ID: 2898245
[TBL] [Abstract][Full Text] [Related]
15. [Synthesis and H2-antihistaminic effect of N,N'-bisheteroaryl N,N'-bisheteroaryl-substituted cyanoguanidines and 2-nitro-1,1-ethenediamines. 17. H2-antihistaminics].
Borchers A; Postius S; Szelenyi I; Schunack W
Arzneimittelforschung; 1984; 34(7):751-4. PubMed ID: 6149751
[TBL] [Abstract][Full Text] [Related]
16. Reversible and irreversible labelling of H1- and H2 -receptors using novel [125I] probes.
Ruat M; Traiffort E; Bouthenet ML; Souil E; Pollard H; Moreau J; Schwartz JC; Martinez-Mir I; Palacios JM; Hirschfeld J
Agents Actions Suppl; 1991; 33():123-44. PubMed ID: 1675831
[TBL] [Abstract][Full Text] [Related]
17. [Racemic guanidinothiazoles with H2-antihistaminic activity. 13 H2-antihistaminics].
Spengler JP; Schunack W
Arzneimittelforschung; 1983; 33(3):377-80. PubMed ID: 6135427
[TBL] [Abstract][Full Text] [Related]
18. Characterization of histamine H2-receptors in human neutrophils with a series of guanidine analogues of impromidine. Are cell type-specific H2-receptors involved in the regulation of NADPH oxidase?
Burde R; Buschauer A; Seifert R
Naunyn Schmiedebergs Arch Pharmacol; 1990 May; 341(5):455-61. PubMed ID: 1694972
[TBL] [Abstract][Full Text] [Related]
19. Specific binding of 3H-tiotidine to histamine H2 receptors in guinea pig cerebral cortex.
Gajtkowski GA; Norris DB; Rising TJ; Wood TP
Nature; 1983 Jul 7-13; 304(5921):65-7. PubMed ID: 6135157
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and histamine H2-receptor antagonist activity of 4-(1-pyrazolyl)butanamides, guanidinopyrazoles, and related compounds.
Buschauer A; Mohr R; Schunack W
Arch Pharm (Weinheim); 1995 Apr; 328(4):349-58. PubMed ID: 7611832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
